Cargando…

LTBP2 inhibits prostate cancer progression and metastasis via the PI3K/AKT signaling pathway

Biochemical recurrence (BCR) is a cause of concern in advanced prostate cancer (PCa). Thus, novel diagnostic biomarkers are required to improve clinical care. However, research on PCa immunotherapy is also scarce. Hence, the present study aimed to explore promising BCR-related diagnostic biomarkers,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiaowen, Tian, Chuanjie, Cheng, Jianbin, Mao, Weipu, Li, Menglan, Chen, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400130/ https://www.ncbi.nlm.nih.gov/pubmed/36034756 http://dx.doi.org/10.3892/etm.2022.11500

Ejemplares similares

ID2 Inhibits Bladder Cancer Progression and Metastasis via PI3K/AKT Signaling Pathway
por: Mao, Weipu, et al.
Publicado: (2021)

SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer
por: Xiao, Zhao-Ming, et al.
Publicado: (2021)

The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway
por: Wang, Jie, et al.
Publicado: (2020)

GABARAPL1 suppresses metastasis by counteracting PI3K/Akt pathway in prostate cancer
por: Su, Wei, et al.
Publicado: (2016)

Astilbin-induced inhibition of the PI3K/AKT signaling pathway decelerates the progression of osteoarthritis
por: Chen, Chunlin, et al.
Publicado: (2020)

DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway
por: Wang, Zhengming, et al.
Publicado: (2018)

Cardamonin inhibits the progression of oesophageal cancer by inhibiting the PI3K/AKT signalling pathway
por: Wang, Zijie, et al.
Publicado: (2021)

KLF2 inhibits colorectal cancer progression and metastasis by inducing ferroptosis via the PI3K/AKT signaling pathway
por: Li, Jia, et al.
Publicado: (2023)

The protective effect of soybean protein‐derived peptides on apoptosis via the activation of PI3K‐AKT and inhibition on apoptosis pathway
por: Yi, Guofu, et al.
Publicado: (2020)

LTBP4 in Health and Disease
por: Su, Chi-Ting, et al.
Publicado: (2021)

Corrigendum: DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway
por: Wang, Zhengming, et al.
Publicado: (2020)

Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway
por: Tong, Chenhao, et al.
Publicado: (2021)

Overexpression of GATA5 Inhibits Prostate Cancer Progression by Regulating PLAGL2 via the FAK/PI3K/AKT Pathway
por: Wang, Qinghua, et al.
Publicado: (2022)

Sophocarpine inhibits tumor progression by antagonizing the PI3K/AKT/mTOR signaling pathway in castration-resistant prostate cancer
por: Weng, Min, et al.
Publicado: (2022)

MDA-19 Suppresses Progression of Melanoma Via Inhibiting the PI3K/Akt Pathway
por: Dang, Ningning, et al.
Publicado: (2018)

AKR1B10 inhibits the proliferation and metastasis of hepatocellular carcinoma cells by regulating the PI3K/AKT pathway
por: Tian, Ke, et al.
Publicado: (2023)

PI3K/Akt/p53 pathway inhibits reovirus infection
por: Zhang, Xiaozhan, et al.
Publicado: (2015)

FGF21 facilitates autophagy in prostate cancer cells by inhibiting the PI3K–Akt–mTOR signaling pathway
por: Dai, Han, et al.
Publicado: (2021)

Sasanquasaponin inhibited epithelial to mesenchymal transition in prostate cancer by regulating the PI3K/Akt/mTOR and Smad pathways
por: Li, Wenfeng, et al.
Publicado: (2022)

NETO2 promotes esophageal cancer progression by inducing proliferation and metastasis via PI3K/AKT and ERK pathway
por: Xu, Jia-cheng, et al.
Publicado: (2021)

IL-17 Affects the Progression, Metastasis, and Recurrence of Laryngeal Cancer via the Inhibition of Apoptosis through Activation of the PI3K/AKT/FAS/FASL Pathways
por: Song, Yang, et al.
Publicado: (2020)

lncRNA MNX1-AS1 promotes prostate cancer progression through regulating miR-2113/MDM2 axis
por: Liang, Dong, et al.
Publicado: (2022)

Pinocembrin Inhibits the Proliferation and Metastasis of Breast Cancer via Suppression of the PI3K/AKT Signaling Pathway
por: Zhu, Xinbing, et al.
Publicado: (2021)

The Role of Polymorphisms in Genes of PI3K/Akt Signaling Pathway on Prostate
por: Xu, Wei, et al.
Publicado: (2019)

ARHGAP20 Expression Inhibited HCC Progression by Regulating the PI3K-AKT Signaling Pathway
por: Liu, Gao, et al.
Publicado: (2021)

Knockdown of FUT11 inhibits the progression of gastric cancer via the PI3K/AKT pathway
por: Cao, Wenpeng, et al.
Publicado: (2023)

CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway
por: Li, Linjin, et al.
Publicado: (2022)

AP4 modulated by the PI3K/AKT pathway promotes prostate cancer proliferation and metastasis of prostate cancer via upregulating L-plastin
por: Chen, Changhao, et al.
Publicado: (2017)

Retracted: Connexin 43 upregulation by dioscin‐inhibited gastric cancer metastasis by suppressing PI3K/Akt pathway
Publicado: (2022)

SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway
por: Zhang, Mao, et al.
Publicado: (2019)

The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
por: Dobbin, Zachary C., et al.
Publicado: (2013)

Research progress on the PI3K/AKT signaling pathway in gynecological cancer
por: Shi, Xiang, et al.
Publicado: (2019)

PI3K/AKT/mTOR pathway in tumor progression of oligodendrogliomas
por: Lisi, Lucia
Publicado: (2020)

Progression and metastasis of small cell lung carcinoma: the role of the PI3K/Akt/mTOR pathway and metabolic alterations
por: Krencz, Ildiko, et al.
Publicado: (2021)

Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway
por: Huang, Jie, et al.
Publicado: (2023)

Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways
por: Chen, Yu-An, et al.
Publicado: (2018)

Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway
por: Cai, Fangzhen, et al.
Publicado: (2020)

Association of Development of Solar Elastosis with Increased Expression of Fibrillin-1, LTBP-2 and Fibulin-4 in Combination with Decreased Expression of LTBP-4
por: MAKINO, Teruhiko, et al.
Publicado: (2021)

Correction: SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway
por: Zhang, Mao, et al.
Publicado: (2019)

Bufalin suppresses the proliferation and metastasis of renal cell carcinoma by inhibiting the PI3K/Akt/mTOR signaling pathway
por: Xie, Jinlin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ouue1fq6uc7q3rf9o1cekai687